Abstract
Several pharmacophore models were previously formulated to account for the actions of nicotinic acetylcholinergic (nACh) agents. Most of these models were developed without express consideration of specific radioligand binding data because such data were not available at the time the models were described. In this review, the ability of these models to account for the binding of nicotinic agents at α4β2 nACh receptors (or rat brain receptors for which α4β2 receptors are the major component) is assessed. It seems that none of the early models can adequately explain the binding of these agents as a group. Furthermore, different series of nicotinic agents behave differently depending upon the nature of terminal amine substituents and the spacer that separates the amine from the pyridine ring. A region of bulk tolerance has been identified that accommodates substituents on some nicotinic ligands, but not the same substituents at seemingly corresponding locations of others. The concept of multiple modes of binding has been previously raised and, clearly, cannot yet be discarded. Nevertheless, new vector models seemingly provide a better picture of nACh receptor binding and account for many of the shortcomings associated with the earlier models.
Keywords: Nicotinic Acetylcholine, pyridine ring
Current Topics in Medicinal Chemistry
Title: Musings on α4β2 Nicotinic Acetylcholine (nACh) Receptor Pharmacophore Models
Volume: 4 Issue: 6
Author(s): Richard A. Glennon, Malgorzata Dukat and Liang Liao
Affiliation:
Keywords: Nicotinic Acetylcholine, pyridine ring
Abstract: Several pharmacophore models were previously formulated to account for the actions of nicotinic acetylcholinergic (nACh) agents. Most of these models were developed without express consideration of specific radioligand binding data because such data were not available at the time the models were described. In this review, the ability of these models to account for the binding of nicotinic agents at α4β2 nACh receptors (or rat brain receptors for which α4β2 receptors are the major component) is assessed. It seems that none of the early models can adequately explain the binding of these agents as a group. Furthermore, different series of nicotinic agents behave differently depending upon the nature of terminal amine substituents and the spacer that separates the amine from the pyridine ring. A region of bulk tolerance has been identified that accommodates substituents on some nicotinic ligands, but not the same substituents at seemingly corresponding locations of others. The concept of multiple modes of binding has been previously raised and, clearly, cannot yet be discarded. Nevertheless, new vector models seemingly provide a better picture of nACh receptor binding and account for many of the shortcomings associated with the earlier models.
Export Options
About this article
Cite this article as:
Glennon A. Richard, Dukat Malgorzata and Liao Liang, Musings on α4β2 Nicotinic Acetylcholine (nACh) Receptor Pharmacophore Models, Current Topics in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1568026043451122
DOI https://dx.doi.org/10.2174/1568026043451122 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis Strategies and Medicinal Value of Pyrrole and its Fused
Heterocyclic Compounds
Medicinal Chemistry Near Infrared Spectroscopy in Healthy Preterm and Term Newborns: Correlation with Gestational Age and Standard Monitoring Parameters
Current Neurovascular Research Adhesion Molecules as Prognostic Biomarkers in Coronary Artery Disease
Current Topics in Medicinal Chemistry Synthesis and Anticancer Evaluation of Sulfur Containing 9-anilinoacridines
Recent Patents on Anti-Cancer Drug Discovery Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents
Current Drug Targets Serial Analysis of Gene Expression (SAGE): 13 Years of Application in Research
Current Pharmaceutical Biotechnology State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging In Silico Prediction of P-glycoprotein Binding: Insights from Molecular Docking Studies
Current Medicinal Chemistry Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein
Anti-Cancer Agents in Medicinal Chemistry The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents
Current Topics in Medicinal Chemistry Structural Biology and Drug Discovery
Current Pharmaceutical Design Update on Antifolate Drugs Targets
Current Drug Targets Phage Therapy for Plant Disease Control
Current Pharmaceutical Biotechnology Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs
Current Drug Targets - Infectious Disorders <i>Caralluma edulis</i> (Apocynaceae): A Comprehensive Review on its Traditional Uses, Phytochemical Profile and Pharmacological Effects
Current Topics in Medicinal Chemistry Inhibitors of Catechol-O-Methyltransferase
CNS & Neurological Disorders - Drug Targets Pharmacotherapy of Acute Lung Injury and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Mechanical Ventilation of the Neonate: Principles and Strategies
Current Respiratory Medicine Reviews Fungal Production and Manipulation of Plant Hormones
Current Medicinal Chemistry Design, Synthesis and Evaluation of Quinoline-based Small Molecule Inhibitor of STAT3
Letters in Drug Design & Discovery